Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
about
Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies.Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk.Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis.Effect of RECK gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.Profiling of alternative polyadenylation sites in luminal B breast cancer using the SAPAS method.Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control studyAssociation between four MMP-9 polymorphisms and breast cancer risk: a meta-analysis.Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics StudyPolymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral CancerPatients' willingness to participate in a breast cancer biobank at screening mammogram.Recklessness as a hallmark of aggressive cancer.Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk.No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility.Does mammographic density reflect the expression of breast cancer markers?Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: a mini-review.Candidate Gene Analysis of Breast Cancer in the Jordanian Population of Arab Descent: A Case-Control Study.Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis.Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European population.Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk.Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women.
P2860
Q31149571-56B39483-1D79-4AA0-978C-F59D17E2B8A0Q33394405-64DB9CFB-A913-4472-A96B-9B20B1846340Q34163439-8668069B-5701-4616-8083-6F0C3F3A1050Q34201053-6AEED2C2-4A42-4A7A-BDD7-DDF7F2938E56Q34599019-A8BE12FA-9D45-497D-A0BF-4FFC4759714FQ34698854-81C09514-B1E6-41D1-8C55-3270E543E60DQ35550737-B185AFBC-50FE-41CB-863D-7645C10ACA0AQ35812861-EB200B27-74F9-447E-BCE2-EBACBCC93661Q35936391-727E7823-00B4-4DC2-B95F-3B07C055A379Q36299328-E9C59688-DBBF-4D48-8083-FDDCCABF785CQ36911942-0F64CEE1-5768-44D5-BAA6-6C78A2A24460Q36921698-F493B71B-C061-4643-B514-38BE3820BFD0Q37148476-30D56601-4EF9-4546-8E67-17DE1CB76179Q37239816-06737AB9-6B13-4F94-B5BA-BAB25DDACEBDQ37351433-24FEDD40-CE7C-44F1-9BA9-804C3D92323FQ37353835-0786A410-639E-4E8F-9D05-ED89F1C885D8Q38101685-592BA607-A54D-40F8-A6A7-73B4E2A68024Q38196442-B1D8508A-82FE-4EE7-AD03-177392D4C054Q38921045-296AEEF1-4DFC-4764-BFDE-11C176CD6AE9Q39805070-B593A7B3-59EB-43A9-B88B-E7EF7EF064C4Q42367521-BB60D012-AAAB-4A37-983F-E9C3386C81B9Q43507964-F52AF642-A710-49F7-87C3-B8EAD1CC2B91Q46414593-47A6D02F-CA75-4865-BC4C-EFC4A919E5EFQ47752875-D7E7C0C1-2DAB-4A62-8DB2-98620B5F3D02Q50863404-ED9C1845-D250-4A78-B89A-63F798FA5D58Q53086095-0B759FAD-99B3-413F-99E2-D3AD30326BBAQ54345992-0A85AE87-DB98-46E4-A605-AC8B55FC7ADCQ54420432-7493F058-82A7-4E17-9C25-B9E21263E7CB
P2860
Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Promoter polymorphisms in matr ...... usceptibility and progression.
@ast
Promoter polymorphisms in matr ...... usceptibility and progression.
@en
Promoter polymorphisms in matr ...... usceptibility and progression.
@nl
type
label
Promoter polymorphisms in matr ...... usceptibility and progression.
@ast
Promoter polymorphisms in matr ...... usceptibility and progression.
@en
Promoter polymorphisms in matr ...... usceptibility and progression.
@nl
prefLabel
Promoter polymorphisms in matr ...... usceptibility and progression.
@ast
Promoter polymorphisms in matr ...... usceptibility and progression.
@en
Promoter polymorphisms in matr ...... usceptibility and progression.
@nl
P2093
P50
P1476
Promoter polymorphisms in matr ...... usceptibility and progression.
@en
P2093
Andrea Altieri
Haixin Lei
Kerstin Enquist
Robert Johansson
P2888
P356
10.1007/S10549-006-9345-2
P407
P577
2006-10-11T00:00:00Z
P6179
1044310400